Related Experiment Video
Updated: Jan 20, 2026

Development of Organoids from Mouse Pituitary as In Vitro Model to Explore Pituitary Stem Cell Biology
Published on: February 25, 2022
Epigenetic control in pituitary tumors
1Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Abstract:
Epigenetically-mediated gene dysregulation is a common feature associated with human pituitary tumorigenesis. The mechanisms leading to these changes, however, remain largely unknown. In this review, we examine changes responsible for DNA and histone modifications as independent, butpotentially interrlated modes of communication effecting chromatin remodeling. The dynamic properties of the enzymes involved in these reactions is highlighted. We use the fibroblast growth factor receptor 2 (FGFR2) as a model through which the p53-regulating melanoma-associated antigen (MAGE) system is governing in pituitary cells. The pathogenetic and potential therapeutic implications are discussed.
Insights
Epigenetic changes like DNA and histone modifications drive pituitary tumors. This review explores how these mechanisms, particularly involving FGFR2 and MAGE systems, contribute to tumor development and offers therapeutic insights.
Area of Science:
- Endocrinology
- Molecular Biology
- Genetics
Background:
- Epigenetic dysregulation is common in human pituitary tumors.
- The precise mechanisms driving these epigenetic changes remain unclear.
- Understanding these alterations is crucial for pituitary tumor research.
Purpose of the Study:
- To review DNA and histone modifications in pituitary tumorigenesis.
- To explore the interplay between epigenetic mechanisms and chromatin remodeling.
- To highlight the role of specific molecular pathways, such as FGFR2 and MAGE, in pituitary cancer.
Main Methods:
- Review of existing literature on epigenetics and pituitary tumors.
- Analysis of DNA and histone modification pathways.
- Examination of enzyme dynamics in epigenetic regulation.
- Case study using the fibroblast growth factor receptor 2 (FGFR2) and melanoma-associated antigen (MAGE) system.
Main Results:
- DNA and histone modifications act as independent yet interconnected regulators of chromatin.
- Enzymes involved in these modifications exhibit dynamic properties.
- The p53-regulating MAGE system, influenced by FGFR2, plays a role in pituitary cells.
- These epigenetic alterations have significant pathogenetic implications.
Conclusions:
- Epigenetic mechanisms are key drivers of pituitary tumorigenesis.
- Further research into these pathways may reveal novel therapeutic targets.
- Targeting epigenetic modifications could offer new treatment strategies for pituitary tumors.
Related Concept Videos
Hypothalamic-Pituitary Axis
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Hormones of the Pituitary Gland
The most abundantly secreted hormone from the anterior lobe is the growth hormone, which controls overall growth by...
The Pituitary Gland
Control System Problem
When forming a closed-loop system, issues can arise if the poles cross into the unstable region, leading to potential...

